SLP Evolution of the Problem - Essay Example

SLP Evolution of the Problem ID Lecturer The rising costs of prescription drugs are a bane that has hurt the cause of the stakeholders at Medicare. This is because these drugs are needed under different circumstances and situations, and need to be purchased by patients and their family members on a regular basis. It is a well-known fact that prescription drugs are preferred by customers all over the world because they are prescribed by doctors who know the best possible remedy for their patients.

It is of paramount importance to know that the rising costs in the wake of these prescription drugs will eventually ask of them to avoid using medicines in the first place. However this cannot happen because the patients require medicines to take care of their ailments and illnesses, and they will keep going to the medics to make sure they remain healed. As far as the stakeholders of Medicare are concerned, the rising costs mean that they need to have more inventories within their ranks, which would mean that the expiry dates of the medicines would be close and hence some of these medicines would be redundant with the passage of time.

The implications of this problem are immense as these could lead to shortage of customers within the markets and hence the stakeholders might feel that they have been hard done by. The Medicare stakeholders have a responsibility with regards to their business, and one must understand the same because the prescription drugs are indeed very quintessential. If the Medicare stakeholders find out alternatives, it is for their own good in the long run (Dukes 2001). When it comes to patients, one can realize the gravity of the scenario since they are the ones who would have to purchase inferior medicines at the expense of the ones that are prescribed by the doctors and medics.

This is in direct contrast of the philosophy of giving the best possible treatment to the patients and as laid down in the Medicare regimes. The politics of international pricing have hurt the cause of these prescription drugs and the stakeholders are bearing the brunt for the same. There needs to be found a way which can tackle such regimes once and for all within the domains of the patients as well as the stakeholders (Harrison 2004). The major players within the field of medicines and health regimes are bringing in changes which have made the prices of these medicines and especially the prescription drugs out of control.

These cost issues should be handled in such a way that attention is paid on the provision of the prescription drugs to the patients and the profit that the stakeholders earn from the same should also be kept in mind (Cleeton 1992). If the Medicare stakeholders devise a way to tackle such issues like pricing of prescription drugs, they would be able to determine the exact manner in which these costs could be curtailed in the coming times and their patients would find it easier to purchase the same as well.

What is really required now is a vision and an approach that can only be termed as positive right from the onset of such discussions. ReferencesCleeton, D (1992). What Does the Consumer Price Index for Prescription Drugs Really Measure? Health Care Financing Review, Vol. 13Dukes, D (2001). What You Should Know about Direct-to-consumer Advertising of Prescription Drugs. Defense Counsel Journal, Vol. 68Harrison, C (2004). The Politics of the International Pricing of Prescription Drugs. Praeger